Ana Sureda

1.9k total citations
15 papers, 544 citations indexed

About

Ana Sureda is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Ana Sureda has authored 15 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Ana Sureda's work include Chronic Lymphocytic Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ana Sureda is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ana Sureda collaborates with scholars based in Spain, United Kingdom and United States. Ana Sureda's co-authors include Rodrigo Martino, Ángel León, Jesús F. San Miguel, Josè Antonio Pérez-Simón, Jordi Sierra, Alberto Álvarez‐Larrán, Juan Carlos Hernández‐Boluda, Montserrat Torrebadell, Emili Montserrat and Francisco Cervantes and has published in prestigious journals such as Blood, Brain Research and British Journal of Haematology.

In The Last Decade

Ana Sureda

15 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Sureda Spain 10 328 176 127 126 126 15 544
Anna Maria Frustaci Italy 15 181 0.6× 287 1.6× 62 0.5× 131 1.0× 111 0.9× 63 515
Masaaki Kume Japan 11 240 0.7× 94 0.5× 143 1.1× 242 1.9× 80 0.6× 27 543
Lidia De Felice Italy 13 485 1.5× 161 0.9× 175 1.4× 222 1.8× 141 1.1× 33 701
D Sainty France 15 523 1.6× 194 1.1× 163 1.3× 226 1.8× 170 1.3× 38 764
Heidrun Boztug Austria 13 208 0.6× 93 0.5× 219 1.7× 81 0.6× 85 0.7× 24 529
K Hirashima Japan 12 295 0.9× 99 0.6× 78 0.6× 99 0.8× 134 1.1× 44 465
Yasuyoshi Morita Japan 11 132 0.4× 123 0.7× 101 0.8× 80 0.6× 51 0.4× 53 333
Marguerite Vignon France 10 114 0.3× 68 0.4× 102 0.8× 90 0.7× 74 0.6× 26 324
Lanier H. Ayscue United States 10 107 0.3× 87 0.5× 46 0.4× 148 1.2× 97 0.8× 11 396
A Jacobs United Kingdom 7 240 0.7× 97 0.6× 92 0.7× 158 1.3× 120 1.0× 12 421

Countries citing papers authored by Ana Sureda

Since Specialization
Citations

This map shows the geographic impact of Ana Sureda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Sureda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Sureda more than expected).

Fields of papers citing papers by Ana Sureda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Sureda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Sureda. The network helps show where Ana Sureda may publish in the future.

Co-authorship network of co-authors of Ana Sureda

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Sureda. A scholar is included among the top collaborators of Ana Sureda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Sureda. Ana Sureda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chabannon, Christian, Annalisa Ruggeri, Silvia Montoto, et al.. (2024). Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: Collection of real-world data in the context of hematopoietic cellular therapies. Best Practice & Research Clinical Haematology. 37(2). 101557–101557. 6 indexed citations
2.
Hamadani, Mehdi, et al.. (2021). Enteropathy-Associated T cell Lymphoma. Current Hematologic Malignancy Reports. 16(2). 140–147. 21 indexed citations
3.
Melilli, Edoardo, Alberto Mussetti, Marco Ruella, et al.. (2021). Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient. Kidney Medicine. 3(4). 665–668. 14 indexed citations
4.
Espinosa, Íñigo, Javier Briones, R Bordés, et al.. (2006). Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma. Annals of Hematology. 85(9). 597–603. 26 indexed citations
5.
Rodríguez, José A., Marı́a Dolores Caballero, Antonio Gutiérrez, et al.. (2005). Prolonged Survival in Patients with Angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO Experience.. Blood. 106(11). 2082–2082. 2 indexed citations
6.
Cervantes, Francisco, Alberto Álvarez‐Larrán, Juan Carlos Hernández‐Boluda, et al.. (2004). Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature. British Journal of Haematology. 127(4). 399–403. 97 indexed citations
7.
Espinosa, Íñigo, Javier Briones, R Bordés, et al.. (2004). PKC-beta 2 Protein Expression Predicts for Poor Response to Chemotherapy and Survival in Patients with Low Risk Diffuse Large B-Cell Lymphoma.. Blood. 104(11). 3258–3258. 3 indexed citations
9.
Pérez-Simón, Josè Antonio, Rodrigo Martino, Adrían Alegre, et al.. (2003). Chronic but not acute graft‐versus‐host disease improves outcome in multiple myeloma patients after non‐myeloablative allogeneic transplantation. British Journal of Haematology. 121(1). 104–108. 78 indexed citations
10.
Olavarría, Eduardo, Josy Reiffers, Ana Sureda, et al.. (2002). The post‐transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase. British Journal of Haematology. 118(3). 762–770. 9 indexed citations
11.
Pérez-Simón, Josè Antonio, Panagiotis Kottaridis, Rodrigo Martino, et al.. (2002). Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. Blood. 100(9). 3121–3127. 190 indexed citations
12.
Subirá, Maricel, Rodrigo Martino, Tomás Franquet, et al.. (2002). Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.. PubMed. 87(5). 528–34. 42 indexed citations
13.
Oteyza, Jaime Pérez de, Ana Sureda, Teresa Ferró, et al.. (1990). Acute lymphoblastic leukemia in an XYY male. Cancer Genetics and Cytogenetics. 49(2). 225–227. 12 indexed citations
14.
Estrada, Carmen, Domingo Triguero, Francesc Xavier Muñoz, & Ana Sureda. (1988). Acetylcholinesterase-containing fibers and choline acetyltransferase activity in isolated cerebral microvessels from goats. Brain Research. 453(1-2). 275–280. 17 indexed citations
15.
Sureda, Ana, et al.. (1971). EFFECT OF MULTIPLE ENTRY ON THE PROPERTIES OF SUPERALLOYS.. PubMed. 21(5). 233–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026